Under construction – not a live service
Sign in
Taking people in United StatesNo phase

MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Status
Recruiting
People taking part
10 people, planned
Started
10 Jun 2024
Expected to end
Jun 2028
Type of study
Interventional
Treatments tested
  • ExAblate Transcranial treatment
Record updated
27 February 2026

Who can take part

Age
21 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 24 criteriaShow less

Who can take part

  • Clinical diagnosis of moderate to severe TSFD with impact in their daily function or occupation function
  • Patients who failed to response or had unsatisfactory response to the first treatment, such as Botulinum toxin treatment or DBS or refuse these alternative options
  • Age greater than 21 and less than 75 years
  • Subjects who are able and willing to give consent and able to attend all study visits,
  • Documented chronic, symptoms for more than 6 months duration
  • Pallidotomy is feasible based on evaluation of imaging studies
  • Patient able to communicate sensations during the ExAblate TcMRgFUS treatment
  • Two members of the medical team have agreed upon inclusion and exclusion criteria

Who cannot take part

  • Patient with contraindications to MRI such as severe claustrophobia and metallic implants incompatible with MRI
  • Severe psychiatric disorder such as uncontrolled depression, anxiety, bipolar disorder, prior attempt at suicide or suicide ideation in preceding 12 months
  • Anticoagulant or antiplatelet medications as well as underlying coagulopathy
  • Inability to provide informed consent, for example due to underlying cognitive impairment or aphasia
  • Subjects exhibiting any behavior(s) consistent with ethanol or substance abuse as defined by the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders(DSM-IV)
  • Severe hypertension (diastolic blood pressure > 100 on medication or persistently elevated systolic blood pressure>140 mmHg despite adequate antihypertensive medications)
  • History of intracranial hemorrhage, traumatic brain injury or thalamic stroke
  • Cerebrovascular disease (multiple cerebrovascular accident's (CVA) or CVA within 6 months)
  • Subjects with life-threatening systemic disease that include and not limited to the following will be excluded from the study participation: HIV, Liver Failure, blood dyscrasias, etc
  • Subjects with a history of seizures within the past year
  • Subjects with unstable cardiac status such as unstable angina pectoris, documented myocardial infarction within 6 months of protocol entry or ejection fraction less than 40
  • Pregnant ladies or women of childbearing age who are sexually active and not using contraception
  • Presence of generalized dystonia or involvement of two or more contiguous body regions (such as Arm along with neck)
  • Life expectancy less than 12 months
  • Presence of intracranial mass or an acute intracranial abnormality
  • Individuals who are not able or willing to tolerate the required prolonged stationary supine position during treatment (can be up to 4 hours of total table time.); -

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 75 years old?

Where in United States

  • University of Maryland Medical CenterBaltimore, United StatesContact: Najme HosseiniTaking people

About the trial

What the trial wants to find out

The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating task specific focal hand dystonias (TSFD). TSFD is a type of dystonia that affects hand movements during specific tasks such as writing, playing instruments or typing, often causing involuntarily movements or cramping.

The group in the trial

  • ExAblate Transcranial treatmentTreatment being tested

    The ExAblate Transcranial system will be used to destroy a small cluster of cells that may be causing the study participant's pain . The ExAblate uses ultrasound to heat a small spot in the brain called globus pallidus internus(GPi). Ultrasound passes through the skin and skull and into the brain to focus on this particular spot.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Phase 1 Clinical Trial for MR Guided Focused Ultrasound (FUS) Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)
Fit questions
Built from NCT06367608, who can take part
Record updated
27 February 2026